$HSON
Hudson Global, Inc.

2021 Q1 Form 10-Q Financial Statement

#000121070821000088 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q3 2020 Q1
Revenue $34.46M $25.41M $24.13M
YoY Change 42.81% -1.35% 49.08%
Cost Of Revenue $21.70M $16.30M $14.30M
YoY Change 51.75% 13.46% 110.57%
Gross Profit $12.70M $9.100M $9.800M
YoY Change 29.59% -20.15% 4.3%
Gross Profit Margin 36.85% 35.81% 40.61%
Selling, General & Admin $12.60M $10.10M $10.30M
YoY Change 22.33% -7.34% -9.65%
% of Gross Profit 99.21% 110.99% 105.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $110.0K $20.00K $24.00K
YoY Change 358.33% 0.0% 33.33%
% of Gross Profit 0.87% 0.22% 0.24%
Operating Expenses $34.44M $26.52M $24.66M
YoY Change 39.7% 4.94% 35.7%
Operating Profit $18.00K -$1.102M -$524.0K
YoY Change -103.44% -323.08% -73.56%
Interest Expense $10.00K $14.00K $79.00K
YoY Change -87.34% -84.09% -74.76%
% of Operating Profit 55.56%
Other Income/Expense, Net -$53.00K $96.00K $41.00K
YoY Change -229.27% -210.34% -210.81%
Pretax Income -$25.00K -$992.0K -$404.0K
YoY Change -93.81% -300.4% -76.32%
Income Tax $178.0K $165.0K $107.0K
% Of Pretax Income
Net Earnings -$203.0K -$1.157M -$511.0K
YoY Change -60.27% -417.86% -73.13%
Net Earnings / Revenue -0.59% -4.55% -2.12%
Basic Earnings Per Share -$0.07 -$0.41 -$0.17
Diluted Earnings Per Share -$0.07 -$0.41 -$0.17
COMMON SHARES
Basic Shares Outstanding 2.891M shares 2.858M shares 3.065M shares
Diluted Shares Outstanding 2.891M shares 2.858M shares 3.065M shares

Balance Sheet

Concept 2021 Q1 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.20M $29.30M $26.10M
YoY Change -11.11% 3.17% -13.86%
Cash & Equivalents $23.15M $29.35M $26.13M
Short-Term Investments
Other Short-Term Assets $1.100M $1.400M $900.0K
YoY Change 22.22% 16.67% -25.0%
Inventory
Prepaid Expenses
Receivables $25.75M $11.92M $12.78M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $41.38M $42.63M $39.90M
YoY Change 3.72% -5.95% -9.38%
LONG-TERM ASSETS
Property, Plant & Equipment $125.0K $132.0K $164.0K
YoY Change -23.78% -30.16% -10.87%
Goodwill $2.088M $0.00
YoY Change
Intangibles $1.320M
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.000K $7.000K $7.000K
YoY Change -28.57% 0.0% 0.0%
Total Long-Term Assets $19.86M $1.367M $1.415M
YoY Change 1303.53% -25.1% -22.55%
TOTAL ASSETS
Total Short-Term Assets $41.38M $42.63M $39.90M
Total Long-Term Assets $19.86M $1.367M $1.415M
Total Assets $61.24M $44.00M $41.31M
YoY Change 48.24% -6.69% -9.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $437.0K $392.0K $697.0K
YoY Change -37.3% -73.58% -29.09%
Accrued Expenses $11.00M $9.200M $6.900M
YoY Change 59.42% 0.0% -8.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $810.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.43M $10.35M $7.571M
YoY Change 51.0% -3.19% -11.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $500.0K $0.00
YoY Change
Other Long-Term Liabilities $193.0K $167.0K $163.0K
YoY Change 18.4% -2.91% 7.95%
Total Long-Term Liabilities $193.0K $167.0K $163.0K
YoY Change 18.4% -2.91% 7.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.43M $10.35M $7.571M
Total Long-Term Liabilities $193.0K $167.0K $163.0K
Total Liabilities $12.83M $11.94M $8.682M
YoY Change 47.78% -9.51% -21.34%
SHAREHOLDERS EQUITY
Retained Earnings -$438.0M -$438.9M -$437.0M
YoY Change 0.21% 0.22% -0.1%
Common Stock $487.1M $486.7M $486.2M
YoY Change 0.18% 0.15% 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.33M $15.33M $15.32M
YoY Change 0.03% 17.8% 22.54%
Treasury Stock Shares 987.0K shares 987.0K shares 987.0K shares
Shareholders Equity $34.15M $32.06M $32.63M
YoY Change
Total Liabilities & Shareholders Equity $46.98M $44.00M $41.31M
YoY Change 13.72% -6.69% -9.9%

Cashflow Statement

Concept 2021 Q1 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income -$203.0K -$1.157M -$511.0K
YoY Change -60.27% -417.86% -73.13%
Depreciation, Depletion And Amortization $110.0K $20.00K $24.00K
YoY Change 358.33% 0.0% 33.33%
Cash From Operating Activities -$2.412M -$500.0K -$2.730M
YoY Change -11.65% -363.16% -56.08%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$10.00K -$10.00K
YoY Change 300.0% -75.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$10.00K -$10.00K
YoY Change 300.0% -71.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $2.239M
YoY Change -100.0% -39.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 -$2.250M
YoY Change -100.0% -100.0% -44.0%
NET CHANGE
Cash From Operating Activities -$2.412M -500.0K -$2.730M
Cash From Investing Activities -$40.00K -10.00K -$10.00K
Cash From Financing Activities $0.00 0.000 -$2.250M
Net Change In Cash -$2.608M -510.0K -$5.218M
YoY Change -50.02% 537.5% -48.93%
FREE CASH FLOW
Cash From Operating Activities -$2.412M -$500.0K -$2.730M
Capital Expenditures -$40.00K -$10.00K -$10.00K
Free Cash Flow -$2.372M -$490.0K -$2.720M
YoY Change -12.79% -357.89% -55.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001210708
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
53 Forest Avenue
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Old Greenwich
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-38704
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
HUDSON GLOBAL, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3547281
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06870
CY2021Q1 dei City Area Code
CityAreaCode
203
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
409-5628
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2687567 shares
CY2021Q1 us-gaap Revenues
Revenues
34461000 USD
CY2020Q1 us-gaap Revenues
Revenues
24131000 USD
CY2021Q1 hson Direct Contracting Costsand Reimbursed Expenses
DirectContractingCostsandReimbursedExpenses
21743000 USD
CY2020Q1 hson Direct Contracting Costsand Reimbursed Expenses
DirectContractingCostsandReimbursedExpenses
14333000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
10590000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
8217000 USD
CY2021Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
2000000 USD
CY2020Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
2081000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
110000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
34443000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
24655000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-524000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
79000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-404000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
178000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-203000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-511000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2891000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3065000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2891000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3065000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-203000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-511000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-226000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-787000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-226000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-787000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-429000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1298000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23150000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25806000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17118000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13445000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
210000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
152000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
904000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
889000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
41382000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
40292000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
737000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
210000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1093000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1037000 USD
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
231000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
241000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
2088000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2088000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1320000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1400000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3000 USD
CY2021Q1 us-gaap Assets
Assets
46981000 USD
CY2020Q4 us-gaap Assets
Assets
45386000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
437000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
576000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10547000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9241000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
448000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
192000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11432000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10009000 USD
CY2021Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
903000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
887000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
302000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
193000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
188000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
12830000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
11106000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3675000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3672000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2688000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2685000 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
487127000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
486825000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-437953000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-437750000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
300000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
526000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
987000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
987000 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
15327000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15325000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
34151000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34280000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46981000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45386000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-203000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-511000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
110000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-70000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
66000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
302000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
144000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3813000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1083000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
94000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1284000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1278000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2412000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2730000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
40000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
10000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2239000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2250000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-156000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-228000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2608000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5218000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26199000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31718000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23591000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26500000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1000 USD
CY2021Q1 hson Interest Received
InterestReceived
10000 USD
CY2020Q1 hson Interest Received
InterestReceived
79000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
299000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
202000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
112000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
67000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
611000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
77000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34280000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
36034000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
34151000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
32630000 USD
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The Company is comprised of the operations, assets, and liabilities of the Company's three regional businesses of Hudson Americas, Hudson Asia Pacific, and Hudson Europe. The Company provides Recruitment Process Outsourcing (“RPO”) permanent recruitment and contracting outsourced recruitment solutions. These services are tailored to the individual needs of primarily mid-to-large-cap multinational companies. The Company's RPO delivery teams utilize state-of-the-art recruitment process methodologies and project management expertise in their flexible, turnkey solutions to meet clients' ongoing business needs. The Company's RPO services include complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    On October 1, 2020, the Company completed its acquisition of Coit Staffing, Inc., which expanded its presence in the technology sector and established a Technology Group located in San Francisco. The Technology Group operates jointly with the Company’s existing teams in the Americas, Asia Pacific, and in Europe, to provide continuous access to knowledge regarding new and emerging technologies in the RPO, Managed Solutions Provider, and Total Talent Solutions space, enabling the Company to better serve its clients around the world.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The Company operates directly in twelve countries with three reportable geographic business segments: Americas, Asia Pacific, and Europe. See Note 13 to the Condensed Consolidated Financial Statements for further details regarding the reportable segments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    In December 2019, a novel strain of coronavirus, referred to as COVID-19, was reported to have originated in Wuhan, Hubei Province, China. On January 30, 2020, the World Health Organization (“WHO”) declared that the virus had become a global public-health emergency. On March 11, 2020, the WHO declared the outbreak to be a pandemic, based on the rapid increase in exposure globally. Many countries around the world have imposed quarantines and restrictions on travel and mass gatherings to slow the spread of the virus. Our business continues to be impacted by the outbreak and the accompanying economic downturn. Some of our customers continue to have instituted hiring freezes, while other customers operating in the banking, pharmaceutical, and technology industries, which may be considered as essential businesses in different jurisdictions, or customers that are more capable of working remotely than other industries, have been allowed to operate as usual. The inability to conduct in-person interviews has also impacted our business. The expected timeline for this reduction in demand for our services remains uncertain and difficult to predict considering the rapidly evolving landscape.</span></div>
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2021Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
12 Country
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2021Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
ACCOUNTING PRONOUNCEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of New Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    On January 1, 2021, the Company adopted Accounting Standards Update (“ASU”) 2019-12, “Income Taxes (“Topic 740”): Simplifying the Accounting for Income Taxes”. The standard simplifies accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The ASU also clarifies and amends existing guidance to improve consistent application. For public business entities, this standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. The adoption of this standard did not have a material impact on the condensed consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">        </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standard Update Not Yet Adopted</span></div>    In June 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss ( “CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under Accounting Standards Codification (“ASC 606”), revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.
CY2021Q1 us-gaap Revenues
Revenues
34461000 USD
CY2020Q1 us-gaap Revenues
Revenues
24131000 USD
CY2021Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
1316000 USD
CY2021Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-334000 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
250000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
117116 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
152171 shares
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
302000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
144000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
178000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-404000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-7.21
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.27
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
672000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
669000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
611000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
594000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-203000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-511000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2891000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3065000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2891000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3065000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
204963 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40771 shares
CY2020Q3 us-gaap Goodwill
Goodwill
0 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1320000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1480000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
160000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1320000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
240000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
310000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
280000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
280000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
210000 USD
CY2021Q1 hson Legal Reserves
LegalReserves
0 USD
CY2020Q4 hson Legal Reserves
LegalReserves
0 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
177000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
139000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
355000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
274000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
121000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
750000 USD
CY2020Q2 hson Proceeds From Government Lending
ProceedsFromGovernmentLending
1326000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
300000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
526000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
300000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
526000 USD
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
34461000 USD
CY2021Q1 hson Segment Reporting Information Revenue Intersegment
SegmentReportingInformationRevenueIntersegment
0 USD
CY2021Q1 us-gaap Revenues
Revenues
34461000 USD
CY2021Q1 hson Revenue Less Certain Direct Costs From External Customers
RevenueLessCertainDirectCostsFromExternalCustomers
12718000 USD
CY2021Q1 hson Intersegment Revenue Less Certain Direct Costs
IntersegmentRevenueLessCertainDirectCosts
0 USD
CY2021Q1 hson Revenue Less Certain Direct Costs
RevenueLessCertainDirectCosts
12718000 USD
CY2021Q1 hson Ebitda Gain Loss
EbitdaGainLoss
75000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
110000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24000 USD
CY2020Q1 hson Segment Reporting Information Intersegment Interest Income Expense Net
SegmentReportingInformationIntersegmentInterestIncomeExpenseNet
0 USD
CY2021Q1 hson Segment Reporting Information Intersegment Interest Income Expense Net
SegmentReportingInformationIntersegmentInterestIncomeExpenseNet
0 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
178000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17118000 USD
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3533000 USD
CY2021Q1 us-gaap Assets
Assets
46981000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24131000 USD
CY2020Q1 hson Segment Reporting Information Revenue Intersegment
SegmentReportingInformationRevenueIntersegment
0 USD
CY2020Q1 us-gaap Revenues
Revenues
24131000 USD
CY2020Q1 hson Revenue Less Certain Direct Costs From External Customers
RevenueLessCertainDirectCostsFromExternalCustomers
9798000 USD
CY2020Q1 hson Intersegment Revenue Less Certain Direct Costs
IntersegmentRevenueLessCertainDirectCosts
0 USD
CY2020Q1 hson Revenue Less Certain Direct Costs
RevenueLessCertainDirectCosts
9798000 USD
CY2020Q1 hson Ebitda Gain Loss
EbitdaGainLoss
-459000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
79000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-404000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12778000 USD
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
164000 USD
CY2020Q1 us-gaap Assets
Assets
41312000 USD
CY2021Q1 us-gaap Revenues
Revenues
34461000 USD
CY2020Q1 us-gaap Revenues
Revenues
24131000 USD
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3533000 USD
CY2021Q1 us-gaap Assets Net
AssetsNet
34151000 USD
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
164000 USD
CY2020Q1 us-gaap Assets Net
AssetsNet
32630000 USD
CY2018Q4 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
1 shares
CY2018Q4 hson Warrantsand Rights Preferred Stockto Common Stock Conversion Treatment
WarrantsandRightsPreferredStocktoCommonStockConversionTreatment
1 shares
CY2018Q4 hson Warrants And Rights Not Exercisable Numberof Days After Public Announcementof Acquiring Person
WarrantsAndRightsNotExercisableNumberofDaysAfterPublicAnnouncementofAcquiringPerson
P10D
CY2018Q4 hson Warrants And Rights Not Exercisable Numberof Days After Tenderor Exchange Offer Is Completed By Acquiring Person
WarrantsAndRightsNotExercisableNumberofDaysAfterTenderorExchangeOfferIsCompletedByAcquiringPerson
P10D
CY2018Q4 hson Warrantsand Rights Optionto Exercise Market Value Multiplierof Purchase Price
WarrantsandRightsOptiontoExerciseMarketValueMultiplierofPurchasePrice
2
CY2018Q4 hson Warrantsand Rights Optionto Exercise Market Value Multiplierof Purchase Price
WarrantsandRightsOptiontoExerciseMarketValueMultiplierofPurchasePrice
2
CY2018Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.001
CY2018Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.001

Files In Submission

Name View Source Status
0001210708-21-000088-index-headers.html Edgar Link pending
0001210708-21-000088-index.html Edgar Link pending
0001210708-21-000088.txt Edgar Link pending
0001210708-21-000088-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hson-20210331.htm Edgar Link pending
hson-20210331.xsd Edgar Link pending
hson-20210331exx311.htm Edgar Link pending
hson-20210331exx312.htm Edgar Link pending
hson-20210331exx321.htm Edgar Link pending
hson-20210331exx322.htm Edgar Link pending
hson-20210331_cal.xml Edgar Link unprocessable
hson-20210331_def.xml Edgar Link unprocessable
hson-20210331_htm.xml Edgar Link completed
hson-20210331_lab.xml Edgar Link unprocessable
hson-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending